Review Article
Inflammation Induced by Perfluorocarbon Liquid: Intra- and Postoperative Use
Table 2
PFCLs used as short-term tamponade [
24,
27–
29].
| PFCL | Pathology | Tamponade time | Follow-up | Study | Results | Inflammation |
| C8F18 | Inferior RD with PVR
| 7 days to air, C3F8, or silicone oil | 14 months | Case series (Drury and Bourke 2011) [24] | Primary reattachment after PFCL and tamponade removal 76% VA improvement 65% VA stable 18% Cataract 60% Macular changes 12% Inflammation 6% IOP > 21 29% Retained PFCL 24% | Iris 6 months after PFCL removal |
| C8F18 | RD with giant retinal tear
| 7–5 days to SF6, C3F8, or silicone oil | 24.5 months | Cases series (Sirimaharaj et al. 2005) [27] | Primary reattachment after PFCL and tamponade removal 80.6% VA improvement 54.8% VA stable 32.3% Cataract 80.5% Macular changes 0% Inflammation 0% Glaucoma 4.8% Retained PFCL 0% | |
| C8F18 | RD with giant retinal tear and PVR | 5 days to C3F8 or silicone oil | 16 months | Cases series (Ventura et al. 2007) [28] | Primary reattachment after PFCL and tamponade removal 80% VA improvement 50% VA stable 20% Inflammation 30% | 30% hypotony with anterior chamber and vitreous cell reaction |
| C10F18 | RD with GRT and PVR | 5 days to fluid | 18 months | Cases series (Bottoni et al. 1994) [29] | Primary reattachment after PFCL removal 82% VA 64% > 20/40 High IOP 30% Inflammation in AC 28% MER 9% ERG normal | 28% AC flare or fibrin reaction |
|
|